Products
Continuous Glucose Monitoring Components
The New Generation Enlite™ Sensor is Medtronic’s latest and smallest sensor, with improved features designed to provide you with exceptional comfort and experience.
Enlite™ Glucose Sensor
- Smaller and more flexible sensor: 80% reduction in size compared to the former Enlite Sensor
- Features an innovation to the sensor adhesive patch to help reduce skin irritations
- Reliable sensor to transmitter connection, which can reduce the likelihood of data gaps. In the event of a lost connection between the sensor and the transmitter, the new Guardian 2 Link transmitter can store up to 10 hours of data
- Insertion is easy with a one button insertion process, a hidden needle during insertion, a 90 degree insertion angle. 85% of patients agreed that insertion with Enlite was pain free**
Guardian™ 2 Link Transmitter
- Small & lightweight: 3.5 x 2.8 x 0.7cm (1.4" x 1.1" x 0.3") and less than 7g (1/4 ounce)
- Sleek thin profile that is shaped to move with you - it won't tug, pull, or pinch
- Wireless transmission means that it works under any clothing
- Waterproof - You can wear the transmitter and glucose sensor while swimming, bathing, or showering. Fully immersible, you can wear it to a depth of 2.4 metres (8 feet) for up to 30 minutes
- If the sensor connection is lost, the transmitter will store up to10 hours of data which will be displayed upon re-connection to the pump
- The Guardian™ 2 Link Transmitter is compatible with the MiniMed™ 640G insulin pump, while the MiniLink™ Transmitter is compatible with the MiniMed™ Paradigm Veo™ System and the Guardian™ REAL-Time CGM System.
Inserting a Guardian™2 Link Transmitter & Enlite™Sensor
Watch this video for further instruction on inserting a Guardian 2 Link transmitter and with Enlite glucose sensor.
References
- -New Generation Enlite™ sensor is indicated for adults and children and only intended for use with Medtronic products: MiniMed™ 640G System, MiniMed™ Paradigm Veo™ System, MiniMed™ Paradigm REAL-Time System, Guardian™ REAL-Time CGM System, iPro™2.
- -New Generation Enlite™ sensor is not intended for use with Medtronic CGMS Gold™ and iPro™.
- *The dynamic suspend feature is based on certain criteria: sensor glucose must be within 70 mg/dL (3.9 mmol/L) of the low limit and predicted to be 20 mg/dL (1.1 mmol/L) above the low limit within 30 minutes AND the pump must not be in the refractory period.
- **Internal data on file; Medtronic Minimed, Inc
- 1Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363:311–320.)
- 2Enhanced Enlite with MiniMed™ 640G System has a MARD of 9.1% [vs. YSI on Day 3]. Cohen O et al. Accuracy of the continuous glucose sensor used with the predictive low glucose management system. Diabetes Technol Ther 2016; 18(S1): A81-A82.
- 3MDT internal data on file CER247
- 4Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464-1476.
- 5Raccah D, Sulmont V, Resnik Y,et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend Study. Diabetes Care. 2009;32(12):2245-2250.
